Evidence map›Paper›PMID 23395178›Full record

ReviewGenomics, proteomics & bioinformatics2013

Interactome mapping: using protein microarray technology to reconstruct diverse protein networks.

Ijeoma Uzoma, Heng Zhu

Abstract readReview
In one paragraph

Review in Genomics, proteomics & bioinformatics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ijeoma UzomaDepartment of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Heng Zhu

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
TCP5: ACTIVE SITE LABELING REAGENT FOR ACETYLTRANSFERASESU54RR020839 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BOEKE, JEF D · 2004 to 2011
$27.4M
Monospecific monoclonal antibodies against human transcription factorsU54HG006434 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI BLACKSHAW, SETH, ZHU, HENG · 2011 to 2015
$13.8M
Proteome Characterization Center: A Genoproteomics Pipeline for Cance ResearchU24CA160036 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2011 to 2016
$10.7M
Lesch-Nyhan Disease: A Model for Complex Genetic, Proteomic & Metabolic PathwaysR24DK082840 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FRIEDMANN, THEODORE · 2008 to 2012
$7.3M
Networks, Pathways and Dynamics of Lysine ModificationU54GM103520 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BADER, JOEL S. · 2012 to 2013
$7.0M
Visual Programming Tool for Integrated Gene/Protein Networks in Cancer ResearchR44CA125807 · NCI · INCOGEN, INC. · PI SASINOWSKI, MACIEK · 2008 to 2011
$3.4M
DNA-Binding Activity of Human Transcription FactorsR01GM076102 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ZHU, HENG · 2006 to 2014
$2.6M
Visual Programming Tool for Integration of Gene and Protein Cancer Profiling DataR43CA125807 · NCI · INCOGEN, INC. · PI SASINOWSKI, MACIEK · 2007 to 2007
$150k
Global analysis of SUMO substrate selection using protein microarray technologyF31GM096716 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI UZOMA, IJEOMA K · 2011 to 2013
$126k
NCI NIH HHS CA125807NCI NIH HHS CA160036NCI NIH HHS P30 CA006973NCI NIH HHS R43 CA125807NCI NIH HHS R44 CA125807NCI NIH HHS U24 CA160036NCRR NIH HHS RR020839NCRR NIH HHS U54 RR020839NHGRI NIH HHS HG006434NHGRI NIH HHS U54 HG006434NIDDK NIH HHS DK082840NIDDK NIH HHS R24 DK082840NIGMS NIH HHS 5F31GM096716NIGMS NIH HHS F31 GM096716NIGMS NIH HHS R01 GM076102NIGMS NIH HHS R01GM076102NIGMS NIH HHS U54 GM103520
6 · The paper itself

Abstract

A major focus of systems biology is to characterize interactions between cellular components, in order to develop an accurate picture of the intricate networks within biological systems. Over the past decade, protein microarrays have greatly contributed to advances in proteomics and are becoming an important platform for systems biology. Protein microarrays are highly flexible, ranging from large-scale proteome microarrays to smaller customizable microarrays, making the technology amenable for detection of a broad spectrum of biochemical properties of proteins. In this article, we will focus on the numerous studies that have utilized protein microarrays to reconstruct biological networks including protein-DNA interactions, posttranslational protein modifications (PTMs), lectin-glycan recognition, pathogen-host interactions and hierarchical signaling cascades. The diversity in applications allows for integration of interaction data from numerous molecular classes and cellular states, providing insight into the structure of complex biological systems. We will also discuss emerging applications and future directions of protein microarray technology in the global frontier.

Indexed as

Protein Array AnalysisAnimalsBiomarkersDNAHost-Pathogen InteractionsHumansLectinsPolysaccharidesProtein Interaction MappingProtein Processing, Post-TranslationalProteinsProteomeSignal TransductionSystems BiologyBiomarkersDNALectinsPolysaccharidesProteinsProteome

Identifiers

PMID23395178
PMCPMC3968920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.